D-0507-2025 Class II Ongoing

Recalled by The Harvard Drug Group LLC — Dublin, OH

FDA drug recall D-0507-2025 was initiated by The Harvard Drug Group LLC on Jun 19, 2025 and is designated Class II. Reason for recall: Defective container; blister packaging inadequately sealed. The recall status is ongoing. Affected quantity: 23,232 cartons.

Recall details

Product Type
Drugs
Report Date
Jul 9, 2025
Initiation Date
Jun 19, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
23,232 cartons

Product description

Gabapentin Capsules, USP, 100 mg, 100 capsules (10x10), blister pack cartons, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN, 46268 USA, NDC 0904-6665-61

Reason for recall

Defective container; blister packaging inadequately sealed.

Distribution pattern

Nationwide

Code information

Lot# M05205, Exp Date 10/2026

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0507-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0507-2025. Report a data issue: hello@regdatalab.com.